EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allele-selective targeting of uromodulin by antisense oligonucleotides reduces aggregates and kidney damage in a mouse model of autosomal dominant tubulointerstitial kidney disease

Sebastian Sjöström iD, Marta Mariniello iD, Guglielmo Schiano iD, Jennifer Lake iD, Sara Botta iD, Alyssa Hill iD, Jonathan Hall iD, Olivier Devuyst iD

Nucleic Acids Research · 10.11.2026 · 54 (21)

DOI: 10.1093/nar/gkag1007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 10.11.2026. Verfasst von Sebastian Sjöström und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland. Hauptthemen laut MEDLINE: Uromodulin, Oligonucleotides, Antisense, Nephritis, Interstitial. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Innovation Center Copenhagen, Innosuisse - Swiss Innovation Agency, European Reference Network for Rare Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal dominant tubulointerstitial kidney disease (ADTKD) arises from gain-of-toxic-function mutations in the UMOD gene coding for uromodulin, the most abundant protein excreted in normal urine. Mutant uromodulin accumulates in the cells lining the thick ascending limb (TAL) of the loop of Henle, leading to intracellular aggregates, cellular stress, and kidney damage. Here, we demonstrate that an antisense gapmer oligonucleotide (ASO) designed against the representative c.553C > A (p.R185S) UMOD mutation produced allele-selective silencing of the mutant messenger RNA and protein in kidney cells. Short-term administration of a murine ASO analogue in the established Umod R186S/+ mouse model of ADTKD suppressed uromodulin and lowered tubular damage, whereas a non-targeting scrambled control was inactive. After a 4-week treatment, ASO accumulation in the Umod R186S/+ kidneys reached ∼320 000 copies per TAL cell, quantified using a sensitive splint-ligation assay. The ASO treatment suppressed premature mutant uromodulin and its toxic aggregates in Umod R186S/+ kidneys, whereas it had no effects on wild-type uromodulin in Umod +/+ kidneys. Notably, the ASO improved tubular function and decreased kidney tubulointerstitial inflammation in Umod R186S/+ mice. This work offers a roadmap for antisense therapy to treat ADTKD-UMOD and substantiates the therapeutic potential of ASOs in disorders of the kidney tubule.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UromodulinOligonucleotides, AntisenseNephritis, InterstitialAnimalsMiceDisease Models, AnimalAllelesKidneyHumansMutationMaleLoop of Henle

Substanzen

UromodulinOligonucleotides, AntisenseUmod protein, mouse

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
  • Mechanisms of Inherited Kidney Disorders, Institute of Physiology, University of Zurich, 8057 Zurich, Switzerland.
  • Institute for Rare Diseases, Saint-Luc Academic Hospital, UCLouvain, 1200 Brussels, Belgium.

ORCID-Profile: Sebastian Sjöström, Marta Mariniello, Guglielmo Schiano, Jennifer Lake, Sara Botta, Alyssa Hill, Jonathan Hall, Olivier Devuyst

Förderung

  • Roche Innovation Center Copenhagen
  • Innosuisse - Swiss Innovation Agency
  • European Reference Network for Rare Kidney Diseases
  • Swiss National Science Foundation
  • University Research Priority Program
  • University of Zurich
  • Fondation Saint-Luc at UCLouvain
  • Innosuisse – Swiss Innovation Agency

Zitieren

APA

Sjöström, S., Mariniello, M., Schiano, G., Lake, J., Botta, S., Hill, A., Hall, J., & Devuyst, O. (2026). Allele-selective targeting of uromodulin by antisense oligonucleotides reduces aggregates and kidney damage in a mouse model of autosomal dominant tubulointerstitial kidney disease. Nucleic Acids Research, 54(21). https://doi.org/10.1093/nar/gkag1007

Vancouver

Sjöström S, Mariniello M, Schiano G, Lake J, Botta S, Hill A, et al. Allele-selective targeting of uromodulin by antisense oligonucleotides reduces aggregates and kidney damage in a mouse model of autosomal dominant tubulointerstitial kidney disease. Nucleic Acids Research. 2026;54(21). doi:10.1093/nar/gkag1007

BibTeX
@article{Sjstrm2026,
  author = {Sjöström, Sebastian and Mariniello, Marta and Schiano, Guglielmo and Lake, Jennifer and Botta, Sara and Hill, Alyssa and Hall, Jonathan and Devuyst, Olivier},
  title = {Allele-selective targeting of uromodulin by antisense oligonucleotides reduces aggregates and kidney damage in a mouse model of autosomal dominant tubulointerstitial kidney disease},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {21},
  doi = {10.1093/nar/gkag1007}
}
Kostenlos starten →